Vanda Pharmaceuticals | Spese Operative

Prezzo Delle Azioni
7.44
Cambio Giornaliero
0.02 0.27%
Mensile
0.40%
Annuale
56.63%
Q1 Previsione
4.24




Spese Operative Cambiamento Data
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Agios Pharmaceuticals USD 129.75M 9.76M 2025-09
Akebia Therapeutics USD 43.82M 16.98M 2025-03
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 223.22M 10.86M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Enanta Pharmaceuticals USD 126.59M 346.51M 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Halozyme Therapeutics USD 136.34M 13.06M 2025-09
Heron Therapeutics USD 38.47M 4M 2024-09
Insmed USD 403.69M 42.4M 2025-09
J&J USD 18.97B 2.38B 2025-12
Lexicon Pharmaceuticals USD 57M 10.54M 2024-06
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
Merck USD 10.16B 558M 2025-12
Minerva Neurosciences USD 4.52M 155.46K 2024-12
Moderna USD 1.28B 232M 2025-09
Novartis USD 9.77B 401M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
PTC Therapeutics USD 207.52M 6.21M 2025-09
Puma Biotechnology USD 49.26M 3.2M 2024-06
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sanofi EUR 10.51B 1.21B 2025-12
Takeda JPY 1.02T 400.98B 2025-12
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
Vanda Pharmaceuticals USD 466M 20.33M 2025-09
Veracyte USD 108.76M 7.09M 2025-09


Vanda Pharmaceuticals Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.